{"title":"TMS-connectivity response as predictor of TMS success","authors":"Alison Knopf","doi":"10.1002/cpu.30969","DOIUrl":"https://doi.org/10.1002/cpu.30969","url":null,"abstract":"","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Active shooter trainings: The harm","authors":"Alison Knopf","doi":"10.1002/cpu.30963","DOIUrl":"https://doi.org/10.1002/cpu.30963","url":null,"abstract":"<p>In “Active Shooter Trainings for Health Care Professionals — Are We Helping or Hurting the Problem?” an opinion article clearly states the dilemma for health care professionals.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"FDA gives guidance on buying medications from websites","authors":"","doi":"10.1002/cpu.30959","DOIUrl":"https://doi.org/10.1002/cpu.30959","url":null,"abstract":"<p>Have you ever been tempted to buy your medicines from an online pharmacy or another website?</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 4","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143595529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Researchers look at quit attempts before success","authors":"Alison Knopf","doi":"10.1002/cpu.30952","DOIUrl":"https://doi.org/10.1002/cpu.30952","url":null,"abstract":"<p>Relapse when giving up opioids, alcohol, cigarettes, or other drugs is common. Now researchers at the Fralin Biomedical Research Institute at VTC's Addiction Recovery Research Center have looked at the number of tries that may be needed before treatment is successful.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 4","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143595533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"HHS criticizes many psychiatric medications for youth","authors":"Alison Knopf","doi":"10.1002/cpu.30951","DOIUrl":"https://doi.org/10.1002/cpu.30951","url":null,"abstract":"<p>The federal Department of Health and Human Services (HHS) has ordered a “Make our Children Healthy Again Assessment” which includes a requirement for a commission to “assess the prevalence of and threat posed by the prescription of selective serotonin reuptake inhibitors, antipsychotics, mood stabilizers, stimulants, and weight-loss drugs.” The ruling also requires the commission to.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 4","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143595532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"NIDA calls for new pathway for cannabis research","authors":"Alison Knopf","doi":"10.1002/cpu.30958","DOIUrl":"https://doi.org/10.1002/cpu.30958","url":null,"abstract":"<p>On January 14, the National Institute on Drug Abuse (NIDA) issued an announcement calling for more research into cannabis and cannabis policy. “The greatly increased availability of cannabis over the last two decades has outpaced our understanding of the public-health impacts of the drug,” NIDA stated. “It is now available for medical purposes in most states, and adults may now purchase it for recreational use in nearly half the states.”</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 4","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143595528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Parental substance use and violent behavior by their children","authors":"Alison Knopf","doi":"10.1002/cpu.30955","DOIUrl":"https://doi.org/10.1002/cpu.30955","url":null,"abstract":"","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 4","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143595527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"GWAS insights can help link genes to pharmacologic treatments","authors":"Alison Knopf","doi":"10.1002/cpu.30950","DOIUrl":"https://doi.org/10.1002/cpu.30950","url":null,"abstract":"<p>The genetic risk for psychiatric disorders may be separate from the way symptoms are currently targeted for certain pharmacologic treatments, according to a recent bioinformatic study. Rather, using the approach of a genome-wide association study (GWAS) could better link risk genes to the best pharmacologic treatments.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 4","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143595531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}